文献速递关节外科骨质疏松与代谢性骨病

弯曲转子间内翻截骨联合骨打压植骨治疗非创伤性股骨头坏死的长期结局

Long-term outcomes of curved intertrochanteric varus osteotomy combined with bone impaction grafting for non-traumatic osteonecrosis of the femoral head.
PubMed 文献 · Bone Joint J · 2021-01-01

这项回顾性比较研究纳入81例非创伤性股骨头坏死患者,37例(40髋)接受弯曲转子间内翻截骨(CVO)联合骨打压植骨(BIG),44例(47髋)仅接受CVO。BIG组平均随访12.2年,CVO组平均随访14.5年。结果显示两组在Harris髋关节评分、Oxford髋关节评分、日本骨科协会髋关节疾病评估问卷、并发症率及以全髋关节置换(THA)和影像学失败为终点的10年生存率上均无显著差异;在CVO成功(术后覆盖比率超过三分之一)的亚组中,BIG组以影像学失败为终点的10年生存率(91.4%)高于CVO组(77.7%),但差异无统计学意义(p=0.079)。结论认为,在恰当选择患者和精确手术的前提下,CVO联合BIG的长期结局良好,但本研究未显示联合BIG能改善治疗结果。

要点

  • CVO联合BIG与单纯CVO在长期功能评分和并发症率上无显著差异。
  • 两组以THA转换和影像学失败为终点的10年生存率无显著差异。
  • CVO成功亚组中BIG组影像学失败10年生存率91.4% vs 77.7%,差异无统计学意义(p=0.079)。

核心结论

  • 在恰当选择患者和精确手术的前提下,CVO联合BIG的长期结局良好,但联合BIG未显示能改善治疗结果。

研究设计与样本

  • 回顾性比较研究,纳入81例非创伤性股骨头坏死患者,BIG组37例(40髋)接受CVO联合BIG,CVO组44例(47髋)仅接受CVO。
  • BIG组平均随访12.2年(10.0至16.5年),CVO组平均随访14.5年(10.0至21.0年)。

主要发现

  • 两组术前和术后Harris髋关节评分(HHS)以及术后Oxford髋关节评分(OHS)和日本骨科协会髋关节疾病评估问卷(JHEQ)均无显著差异。
  • 两组并发症率相当。
  • 以全髋关节置换(THA)转换和影像学失败为终点的10年生存率在两组间无显著差异。
  • CVO成功(术后覆盖比率超过三分之一)亚组中,BIG组以影像学失败为终点的10年生存率为91.4%,CVO组为77.7%,差异无统计学意义(p=0.079)。

关键数值与推荐

  • CVO成功的判定标准为术后覆盖比率超过三分之一。
  • 以影像学失败为终点的10年生存率:BIG组91.4%,CVO组77.7%(p=0.079)。

临床怎么用

  • 对于非创伤性股骨头坏死,CVO联合BIG可作为治疗选择,但需恰当选择患者并精确手术。
  • 联合BIG并未显示额外获益,临床决策时应综合评估。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

AIMS: We compared the clinical outcomes of curved intertrochanteric varus osteotomy (CVO) with bone impaction grafting (BIG) with CVO alone for the treatment of osteonecrosis of the femoral head (ONFH). METHODS: This retrospective comparative study included 81 patients with ONFH; 37 patients (40 hips) underwent CVO with BIG (BIG group) and 44 patients (47 hips) underwent CVO alone (CVO group). Patients in the BIG group were followed-up for a mean of 12.2 years (10.0 to 16.5). Patients in the CVO group were followed-up for a mean of 14.5 years (10.0 to 21.0). Assessment parameters included the Harris Hip Score (HHS), Oxford Hip Score (OHS), Japanese Orthopaedic Association Hip-Disease Evaluation Questionnaire (JHEQ), complication rates, and survival rates, with conversion to total hip arthroplasty (THA) and radiological failure as the endpoints. RESULTS: There were no significant differences in preoperative and postoperative HHS or postoperative OHS and JHEQ between the BIG group and the CVO group. Complication rates were comparable between groups. Ten-year survival rates with conversion to THA and radiological failure as the endpoints were not significantly different between groups. Successful CVO (postoperative coverage ratio of more than one-third) exhibited better ten-year survival rates with radiological failure as the endpoint in the BIG group (91.4%) than in the CVO group (77.7%), but this difference was not significant (p = 0.079). CONCLUSION: Long-term outcomes of CVO with BIG were favourable when proper patient selection and accurate surgery are performed. However, this study did not show improvements in treatment results with the concomitant use of BIG. Cite this article: Bone Joint J 2021;103-B(4):665-671.

来源:Bone Joint J,查看原文。版权归原作者所有。

引用

  1. Osawa Y, Seki T, Okura T, et al. Long-term outcomes of curved intertrochanteric varus osteotomy combined with bone impaction grafting for non-traumatic osteonecrosis of the femoral head. Bone Joint J. 2021. PMID: 33789486. doi:10.1302/0301-620X.103B4.BJJ-2020-1107.R1

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。